These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [Abstract] [Full Text] [Related]
10. Suppression of collagen induced arthritis in mice utilizing plasmid DNA encoding interleukin 10. Miyata M, Sasajima T, Sato H, Saito A, Saito A, Iriswa A, Sato Y, Kasukawa R. J Rheumatol; 2000 Jul; 27(7):1601-5. PubMed ID: 10914840 [Abstract] [Full Text] [Related]
14. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Yoshino S, Sasatomi E, Ohsawa M. Immunology; 2000 Apr; 99(4):607-14. PubMed ID: 10792509 [Abstract] [Full Text] [Related]
15. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis. Chu CQ, Londei M. J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020 [Abstract] [Full Text] [Related]
16. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models. Cantaert T, Teitsma C, Tak PP, Baeten D. Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233 [Abstract] [Full Text] [Related]
19. The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice. Yoshino S, Ohsawa M. Br J Pharmacol; 2000 Apr; 129(7):1309-14. PubMed ID: 10742285 [Abstract] [Full Text] [Related]